Ikarian Capital »

Karuna Therapeutics Ord shares owned by Ikarian Capital

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 59k 316.51
2022-06-30 $25M 200k 126.52
2022-03-31 $6.3M 50k 126.80
2020-12-31 $12M 120k 101.60

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord